MNKD: MannKind Corp. Operatsion rentabellik

mannkindcorp.com (MNKD) brendining ramzi va logotipi

Ushbu GURU.Markets grafigidagi MannKind Corporation (MNKD) operatsion marjasi -2.00 metrik qiymatini ko'rsatmoqda. Ushbu tendentsiya insulin yetkazib berishning noyob usuli bilan bog'liq bo'lib, bunda patent himoyasi va sarf materiallariga bo'lgan talab sotuvlarning barqarorligini kafolatlaydi. United Therapeutics kompaniyasidan kelayotgan to'lovlar va o'pka portfelining ishlab chiqilishi aksiyalar narxining ko'tarilishini rag'batlantirmoqda. Sherikliklardan keladigan barqaror pul oqimi biznes uchun mustahkam moliyaviy poydevor yaratadi.

MNKD: MannKind Operatsion faoliyat rentabelligi 04.07.2022 - 20.11.2026

MannKind (MNKD) kompaniyasining tahliliy kesimlari

- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning fundamental baholanishi:Afrezza, MNKD
mannkindcorp.com tayyor mahsulotlari

MannKind Corporation (MNKD) inhalatsiya tizimlari zavodlarida quvvatdan foydalanishning barqarorligi operatsion samaradorlikni tahlil qilish uchun asos bo'lib xizmat qiladi. Ushbu ko'rsatkich asosiy biznesdan foizlar va soliqlar to'lanishidan oldingi foyda ulushini hisoblaydi. Yakuniy operatsion marjaning tendentsiyasi qadoqlash liniyalarini avtomatlashtirishning xarajatlarni kamaytirishga ta'sirini aks ettiradi. Investorlar ushbu ko'rsatkichning o'sishini ichki jarayonlarning optimallashtirilishi deb talqin qilishlari kerak. Aktiv yuqori texnologiyali sog'liqni saqlash sektoriga tegishli.

Raqobatdosh kompaniyalar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.